Regresar a Artículos Indexados
  • JOURNAL OF RHEUMATOLOGY AND ARTHRITIC DISEASES// (VOL. 3, ISSUE 2)

    Volumen: 3, Numero: 2, Páginas: [04]p.

    AVAILABILITY OF DRUGS FOR THE TREATMENT OF PARKINSON?S DISEASE, PHARMACY NETWORK IN THE MUNICIPALITY RIOBAMBA

    Abstract

    Background: Parkinson?s disease is a chronic, degenerative disorder of the dopamine-producing cells, a predominantly midbrain level, the processes involved in engine control system. Its déficit is manifested by a progressive loss of the ability to coordinate movements.Objectives: to determine the availability of drugs to control the disease in pharmacies Riobamba municipality. Material and Methods: A descriptive study by conducting surveys in 20 pharmacies, 78 patients and 2 basic hospitals. In addition, also they surveyed six health professionals.Results: the 90 percent of the extra hospital pharmacies have antiparkinsonians availability of drugs, but only 5 percent have biperideno and levodopa. 50 percent of hospital pharmacies does not guarantee a continuous supply of these drugs.Conclusions: Antiparkinsonians availability of drugs in hospital pharmacies is low. In the network of retail pharmacies there antiparkinsonians availability of drugs, but however the most commonly used drugs (biperideno and levodopa) have poor coverage. The drug most commonly used to treat Parkinson?s is dopamine, in commercial form because of its low cost and effectiveness. There is difficulty in acquiring medicines antiparkinsonians the afore mentioned issues, which results in inadequate control of the disease and low levels of perceived of quality of life.


    Keywords


    Quality of life, Chronic disorder, Parkinson, Motor system


    Resumen

    No disponible


    Palabras Clave


    No disponible





    Acceder